logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
N

Neal D. Shore

Carolina Urologic Research Center

84H-index
1.3KPaper Count
4.5WCitation Count
Published Papers 390
Publication Date
logo
Correspondence: persistence, progression, and PSA: what exactly does DEAR-EXT compare? Yanping Zhu, Xiaohui Wang, Yang Zhang, Shuangwu Lv
errProstate Cancer and Prostatic Diseases
IF5.8
err2026-08-18
err0
errOAAI
errNeal D. Shore; Daniel J. George; Nasreen Khan; Niculae Constantinovici; Guifang Chen; Mercedeh Ghadessi; Vlasta Hlebec; Alicia K. Morgans
errShare
errSave
Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice
errFuture Oncology
IF2.6
err2026-07-09
err0
errOAAI
errStephen J. Freedland; Neal D. Shore
errShare
errSave
Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer
errInternational Journal of Clinical Oncology
IF2.8
err2026-06-25
err0
errOAAI
errNeal Shore; Nguyen; Barinder Kang; Amrita Sawhney; Clare Byrne; Jackson Tang; Magdaliz Gorritz; Chi-Chang Chen; Jeetvan Patel
errShare
errSave
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial
errProstate Cancer and Prostatic Diseases
IF5.8
err2026-06-20
err0
errOAAI
errQuoc-Dien Trinh; Daniel J. George; Neal Shore; Egils Vjaters; David Olmos; Andrea Juliana P. de Santana Gomes; Augusto Cesar de Andrade Mota; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Kunhi Parambath Haresh; Fred Saad
errShare
errSave
Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocols
errFuture Oncology
IF2.6
err2026-05-10
err0
PREAI
errNeal D. Shore; Karim Fizazi; Michael Thomas Schweizer; Elena Castro; Arun A. Azad; Daniel J. George; Karine Martins da Trindade; Hao Zeng; Nitin Shrivastava; Svitlana Tonkovyd; Amy Bock; Srilakshmi Nekkalapudi; Yiyun Tang; Stella Lin; Neeraj Agarwal
errShare
errSave
DURVALUMAB IN COMBINATION WITH BACILLUS CALMETTE-GUéRIN FOR BACILLUS CALMETTE-GUéRIN-NAÏVE, HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER: PRIMARY RESULTS FROM A US-BASED, PHASE IIIB, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY (PATAPSCO)
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errJayram, Gautam; Shore, Neal D.; Tyson, Mark; Pieczonka, Christopher; Treasure, Peter; Gadzinski, Adam; Mazzarella, Brian; Hodari, Moana; Glover, Kara; Hardikat, Sushant; Hahn, Noah M.
errShare
errSave
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial
errJournal of Urology
IF6.8
err2026-05-01
err6
PREAI
errShore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J.
errShare
errSave
Real-world treatment patterns in patients with biochemical recurrence after local prostate cancer therapy
errFuture Oncology
IF2.6
err2026-04-29
err0
errOAAI
errRana R. McKay; Nasreen Khan; Neal D. Shore; Guifang Chen; Vlasta Hlebec; Shankar Srinivasan; Daniel E. Spratt
errShare
errSave
Health-related Quality of Life With ARPIs in mHSPC: Insights From a Network Meta-analysis
errEuropean Urology Focus
IF5.6
err2026-04-18
err0
errOAAI
errNeal D. Shore; Noman Paracha; Howard Thom; Philip Orishaba; Elaine Gallagher; Alicia K. Morgans
errShare
errSave
Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial
errEuropean Journal of Cancer
IF7.1
err2026-04-05
err0
PREAI
errBertrand Tombal; Maha Hussain; Fred Saad; Karim Fizazi; Neal Shore; Evgeny Kopyltsov; Martin Bögemann; Maria J Mendez-Vidal; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Matthew R. Smith
errShare
errSave
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
errCancer
IF5.1
err2026-01-01
err0
PREAI
errGebrael, Georges; Agarwal, Neeraj; Morgans, Alicia K.; Vince, Randy; Swami, Umang; Jia, Angela Y.; Zaorsky, Nicholas; Chehade, Chadi Hage; Ozay, Zeynep Irem; Malone, Shawn; Morgan, Scott C.; Wallis, Christopher J. D.; Kishan, Amar U.; Barata, Pedro C.; Chowdhury, Simon; Garcia, Jorge A.; Sheng, Iris; Brown, Jason R.; Small, Eric J.; Sun, Yilun; Shore, Neal D.; Saad, Fred; Spratt, Daniel E.; Roy, Soumyajit
errShare
errSave
Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and Challenges
errEuropean Urology Focus
IF5.6
err2025-12-18
err0
errOAAI
errNeal D. Shore; Stephen J. Freedland; Lisa G. Horvath; Joe M. O’Sullivan; Ugo De Giorgi; Edward C. Ray; Ashley E. Ross; Yiyun Tang; David Russell; Kenneth K. Iwata; Matt Rosales; Arijit Ganguli; Bertrand Tombal
errShare
errSave
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
errNature Communications
IF15.7
err2025-12-17
err0
errOAAI
errSoumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt
errShare
errSave
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data
errProstate Cancer and Prostatic Diseases
IF5.8
err2025-12-09
err0
errOAAI
errNeal Shore; Alicia K. Morgans; Noman Paracha; Elaine Gallagher; Howard Thom; David Aceituno; Philip Orishaba; Stephen Stefani; Quoc-Dien Trinh; Christopher J. D. Wallis; Keith R. Abrams; Martin Boegemann
errShare
errSave
Response to Letter to the Editor Regarding: ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'
errAdvances in Therapy
IF4
err2025-11-28
err0
errOAAI
errMehmet A. Bilen; Benjamin Lowentritt; Ibrahim Khilfeh; Carmine Rossi; Shawn Du; Frederic Kinkead; Lilian Diaz; Dominic Pilon; Lorie Ellis; Neal D. Shore
errShare
errSave
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
errEuropean Journal of Cancer
IF7.1
err2025-11-21
err0
PREAI
errUrsula M. Vogl; Sara Merler; Antonio Angrisani; Fabio Turco; Ian D. Davis; Jason A. Efstathiou; Karim Fizazi; Nicholas D. James; Neal Shore; Eric J. Small; Matthew R. Smith; Christopher J. Sweeney; Bertrand Tombal; Thomas Zilli; Ken Herrmann; Aurelius Omlin; Silke Gillessen
errShare
errSave
Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age
errEuropean Journal of Cancer
IF7.1
err2025-11-15
err0
PREAI
errNeal D. Shore; Ugo De Giorgi; Matko Kalac; Yiyun Tang; Ruslan Croitoru; Matt Rosales; Melissa J. Huynh; Igle J. de Jong; Christopher P. Evans; Flavio M. Carcano; Stephen J. Freedland
errShare
errSave
Corrigendum to Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study [European Journal of Cancer Volume 213, December 2024, 115078]
errEuropean Journal of Cancer
IF7.1
err2025-11-13
err0
PREAI
errArun A. Azad; Karim Fizazi; Nobuaki Matsubara; Fred Saad; Ugo De Giorgi; Jae Young Joung; Peter C.C. Fong; Robert J. Jones; Stefanie Zschäbitz; Jan Oldenburg; Neal D. Shore; Curtis Dunshee; Joan Carles; Andre P. Fay; Xun Lin; Liza DeAnnuntis; Nicola Di Santo; Michael A. Zielinski; Neeraj Agarwal
errShare
errSave
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
errShare
errSave
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)
errFUTURE ONCOLOGY
IF2.6
err2025-11-01
err0
PREAI
errMorgans, Alicia K.; Chehrazi-Raffle, Alex; Niazi, Tamim; Shore, Neal D.; Ross, Ashley E.; Roder, Andreas; Gomes, Andrea Juliana; Supiot, Stephane; Barthelemy, Philippe; Hatano, Koji; Ruiz, Carmen Belen Congregado; Yoshida, Soichiro; Herrera-Imbroda, Bernardo; Gratton, Matthieu; Gschwend, Jurgen E.; Hope, Thomas A.; Joensuu, Heikki; Kuss, Iris; Le Berre, Marie-Aude; Dimova-Dobreva, Miryana; Fizazi, Karim
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
P
Peter R. Carroll
H-index: 149 · Papers: 1.4K
P
Peter T. Scardino
H-index: 149 · Papers: 1.2K
View more